Jazz Pharmaceuticals plc · Biotechnology

JAZZJazz Pharmaceuticals plc

Reports 2026-11-02 · MonReaction day 11-03upcoming

Before the print · expectations11 days to the print

Street consensus

−$3.90EPS
$1.23BRevenue

No past prints on file yet.

What the record doesn't tell you

Which way does JAZZ go on 11‑02?

  • Model lean for 11-02, and the evidence behind it
  • Move band, P10 – P90
  • Last 8 prints, quarter by quarter
  • Peers that already reported, and how they traded
Start 30-day free trialFull access · no card requiredHave an account? Sign inThe lean freezes the night before the print.

The print · 8-K and callupcoming · 2026-11-02

Revenue—
est. $1.23B
EPS—
est. −$3.90
Guidance—read from the 8-K once filed

Lean, stance and evidence on this page are model outputs, not investment advice. Trade at your own risk. Disclaimer →

Jazz Pharmaceuticals earnings preview: what the record says

Jazz Pharmaceuticals (JAZZ) is scheduled to report earnings on Nov 2, 2026. The consensus estimate calls for EPS of −$3.90 on revenue of $1.23B.

Figures come from NextPick's earnings-reaction ledger and the options market. Not investment advice.

JAZZ earnings: key questions

When is JAZZ's next earnings date?

Jazz Pharmaceuticals is scheduled to report on Nov 2, 2026.

What are JAZZ's earnings expectations?

Analysts expect EPS of −$3.90 on revenue of $1.23B for the quarter.